Is antibiotic need for ic bleed?
intracerebral hemorrhage antibiotic prophylaxis
intracerebral hemorrhage infection prophylaxis management
antibiotic prophylaxis intracerebral hemorrhage ICH guidelines 2024
Drug orders for ic bleed
ICH intracerebral hemorrhage drug orders medications AHA guidelines 2022 2024
https://emottawablog.com/2023/01/spontaneous-intracerebral-h…
| Drug | Dose | Route |
|---|---|---|
| Labetalol | 10-20 mg IV over 1-2 min; repeat q10 min (max 300 mg) | IV bolus or infusion |
| Nicardipine | 5 mg/hr infusion, titrate up by 2.5 mg/hr q5-15 min (max 15 mg/hr) | IV infusion |
| Hydralazine | 10-20 mg IV q4-6h | IV bolus |
| Enalaprilat | 1.25 mg IV q6h | IV (avoid in renal failure) |
Avoid rapid drop below 130 mmHg. Avoid nitroprusside (causes ICP elevation).
| Anticoagulant | Reversal Agent | Dose |
|---|---|---|
| Warfarin | PCC (4-factor) | 25-50 U/kg IV + Vitamin K1 5-10 mg IV slow infusion |
| Dabigatran | Idarucizumab (Praxbind) | 5 g IV (2 × 2.5 g doses, ≤15 min apart) |
| Apixaban / Rivaroxaban | Andexanet alfa | 400-800 mg IV bolus + 480-960 mg infusion over 2 hrs |
| Heparin infusion | Protamine sulfate | 1 mg per 100 units heparin IV (slow) |
| LMWH (<12 hrs) | Protamine sulfate | 1 mg per 1 mg enoxaparin (max 50 mg) |
Note: PCC is preferred over FFP. Platelet transfusion is NOT recommended for antiplatelet-related ICH (worsens outcomes). Use only for severe thrombocytopenia.
| Drug | Dose | Notes |
|---|---|---|
| Mannitol 20% | 0.25-1 g/kg IV over 20 min | Repeat q4-6h; monitor serum osmolality (<320 mOsm/L) |
| Hypertonic saline (3%) | 150-250 mL IV over 30 min | Alternative to mannitol; monitor Na |
| Fentanyl | 2-3 mcg/kg IV | Before intubation - blunts ICP spike from laryngoscopy |
Dexamethasone / corticosteroids are NOT recommended - no benefit, possible harm.
| Scenario | Drug | Dose |
|---|---|---|
| Active seizure / status | Lorazepam | 0.1 mg/kg IV (4 mg typical dose); repeat once |
| Active seizure - load | Levetiracetam | 1000-3000 mg IV loading dose |
| Active seizure - alternative | Fosphenytoin | 15-20 mg PE/kg IV |
Prophylactic antiseizure medications are NOT recommended in the absence of seizures (2022 AHA/ASA - no benefit, worsens cognitive outcomes).
| Drug | Dose | Indication |
|---|---|---|
| Pantoprazole / Omeprazole | 40 mg IV/PO OD | GI stress ulcer prophylaxis |
| Enoxaparin | 40 mg SC OD (after 24-48 hrs, once bleed stable) | DVT prophylaxis (pneumatic compression first) |
| Paracetamol / Acetaminophen | 650 mg PO/IV q4-6h | Fever control - normothermia target <37.5°C |
| NS (0.9% NaCl) | 75-100 mL/hr | Maintenance fluids - avoid hypotonic solutions |
| Insulin (sliding scale) | Per protocol | Tight glucose 140-180 mg/dL; avoid hypoglycemia |
| Drug | Reason |
|---|---|
| Aspirin / NSAIDs | Worsen bleeding |
| Corticosteroids | No benefit, may increase infections |
| tPA / thrombolytics | Contraindicated |
| Prophylactic antibiotics | Not indicated for hemorrhage itself |
| Prophylactic antiseizure drugs | No benefit per 2022 AHA/ASA |
| Platelet transfusion (antiplatelet ICH) | Worsens outcomes |
Source: Bradley and Daroff's Neurology in Clinical Practice, 2022 AHA/ASA ICH Guidelines
Inj for decreasing the bp in icu with hr 65
IV antihypertensive ICU low heart rate 65 nicardipine clevidipine hydralazine dosing
| Drug | Dose | Onset | Notes |
|---|---|---|---|
| Nicardipine (1st line) | Start 5 mg/hr IV infusion; titrate up by 2.5 mg/hr every 5-15 min; max 15 mg/hr | 5-15 min | Dihydropyridine CCB - lowers afterload, does NOT slow HR. Best for ICH/neuro ICU. Does not raise ICP |
| Clevidipine | Start 1-2 mg/hr IV infusion; titrate by doubling every 90 sec; max 32 mg/hr | 2-4 min | Ultra-short acting CCB (half-life ~1 min), easily titratable. Safe in hepatic/renal failure. May cause mild reflex tachycardia |
| Hydralazine | 10-20 mg IV bolus over 20 min; repeat q4-6h PRN | 10-30 min | Direct arterial vasodilator. Actually preferred with bradycardia - causes reflex tachycardia (will slightly raise HR from 65). Unpredictable in dose response |
| Drug | Why to Avoid |
|---|---|
| Labetalol | Alpha + beta blocker - will slow HR further (bradycardia risk) |
| Esmolol | Pure beta-blocker - significant HR reduction, avoid |
| Metoprolol IV | Slows HR, contraindicated |
| Sodium nitroprusside | Avoid in neuro ICU (raises ICP via vasodilation); cyanide toxicity with prolonged use |
| Clinical Context | Preferred Drug |
|---|---|
| ICH / Neuro ICU | Nicardipine infusion (does not raise ICP, smooth titration) |
| HR 65 with bradycardia trend | Hydralazine IV (reflex tachycardia actually helps) or Nicardipine |
| Need very fast/precise control | Clevidipine (half-life 1 min, best titratability) |
| Pulmonary edema with HTN | Nitroglycerin (reduces preload + afterload) |
| Renal / hepatic failure | Clevidipine (ester hydrolysis in blood, organ-independent) |
Inj. Nicardipine 5 mg/hr IV infusion
→ Titrate by 2.5 mg/hr every 5-15 min
→ Target SBP < 140 mmHg
→ Max 15 mg/hr
→ Continuous BP and HR monitoring
Inj. Hydralazine 10-20 mg IV slow bolus over 20 min
→ Repeat q4-6h as needed
→ Monitor BP every 5-15 min after each dose